Join Sona Nanotech for a live investor webinar hosted by David Regan, CEO and Len Pagliaro PhD, CSO on which they will discuss the development of Sona’s pre-clinical Targeted Hyperthermia Therapy, which leverages Sona’s biocompatible Gold Nanorods.
The webinar will include a Q&A session.